Cervical Plexus Hydrodissection With D5W for PTSD Versus Delayed Treatment/Usual Care

Status: Recruiting
Location: See all (4) locations...
Intervention Type: Procedure
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

PTSD is a chronic mental health condition that drastically reduces an individual's quality of life Dextrose injection with a small needle has been used for chronic pain patients and observational results have shown it to be effective in reducing anxiety, brain fog, and depression in patients with PTSD. This randomized trial will compare dextrose injection with a delayed/usual treatment control.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Maximum Age: 90
Healthy Volunteers: t
View:

• Not involved in another study of PTSD treatment

• Reliable transportation

• Comfortable with computers

• Tried 2 or more medications for treatment of PTSD symptoms

• Tried 2 or more non-medication treatments for PTSD symptom

• No known life-threatening illness

• Not taking daily narcotics

• Not having 3or more alcoholic drinks on an average day

• No active suicidal plans

• No major surgery plans

• No major life stress that might interfere with completing study

• Symptoms for more than 1 year

• Not planning to move for next 18 months.

• Living within an hour of Kelowna or Victoria, British Columbia, Portland, Oregon, Madison, Wisconsin, or Hong Kong

• Wiling to provide 2 email and 2 phone contact methods

• Willing to answer questions on multiple occasions over the course of a year.

• Willing to be assigned to 3 months of usual care treatment

• No diagnosis of schizophrenia, Borderline Personality Disorder, or Bipolar Disorder.

• No severe needle phobia

• Chronic pain ≤ 5/10

• PCL-C score ≥ 50

Locations
United States
Kentucky
Danesh Mazloomdoost
RECRUITING
Lexington
Oregon
Paul W. Johnson, D.O., Clinic.
RECRUITING
Portland
Northwest Regenerative Orthopedics
RECRUITING
Tigard
Wisconsin
Eric Phillippi M.D. Clinic
RECRUITING
Madison
Contact Information
Primary
Kenneth D Reeves, M.D.
DeanReevesMD@gmail.com
9133621600
Backup
Kenneth D Reeves, M.D.
ReevesOffice@gmail.com
9133621600
Time Frame
Start Date: 2023-07-10
Estimated Completion Date: 2027-10-01
Participants
Target number of participants: 24
Treatments
Experimental: BCPHD-D5W with usual care
Bilateral cervical plexus hydrodissection with D5W (BCPHD-D5W) at 0, 2, 4, and 8 weeks.~All helpful treatment methods already underway are continued. Other new treatment methods are discouraged.
Active_comparator: Waiting period with usual care
All helpful treatment methods already underway are continued. Other new treatment methods are discouraged.
Sponsors
Leads: Dr. Dean Reeves Clinic
Collaborators: Eric Phillippi, M.D., Danesh Mazloomdoost, Ryan Wood, N.D., Paul Johnson, D.O.

This content was sourced from clinicaltrials.gov

Similar Clinical Trials